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Abstract. Post-translational modification of chroma-
tin is emerging as an increasingly important regulator
of chromosomal processes. In particular, histone
lysine and arginine methylation play important roles
in regulating transcription, maintaining genomic in-
tegrity, and contributing to epigenetic memory. Re-
cently, the use of new approaches to analyse histone
methylation, the generation of genetic model systems,
and the ability to interrogate genome wide histone
modification profiles has aided in defining how
histone methylation contributes to these processes.
Here we focus on the recent advances in our under-
standing of the histone methylation system and
examine how dynamic histone methylation contrib-
utes to normal cellular function in mammals.
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Introduction
Since histones were first discovered over one hundred
years ago a great deal has been learned about the
structure and function of these small basic proteins
[1]. Importantly, histone molecules interact to form a
scaffolding unit capable of compacting DNA within
the relatively small confines of the nucleus [2].
Compaction is achieved by wrapping DNA around a
globular histone octamer composed of a tetramer of
histone H3/H4 and two dimers of H2A/H2B. Togeth-
er, this DNA-protein structure is called a nucleosome
and forms the basic repeated unit of chromatin. This
classical view of chromatin as a simple structural
entity has recently been superseded by a wide body of
evidence demonstrating that nucleosome deposition,
subunit composition, and post-translational modifica-
tion can profoundly affect how chromatin function is
regulated. For example, nucleosome placement over
defined regulatory elements can impact how tran-
scription factors recognize DNA and regulate tran-
scription[3],incorporationofhistonevariantsintothe
octamercandefinehowthenucleosomefunctions[4],
and post-translational modification of histone tails
can act as nucleation sites for factors involved in
chromatin regulation and metabolism [5, 6].
Over the past decade it has become increasingly clear
thatpost-translationalmodificationofhistonesplaysa
central role in regulating information that is stored
within DNA. Many of these modifications are found
on the N-terminal histone tails that protrude from the
globular core of the nucleosome and include: phos-
phorylation, acetylation, ribosylation, ubiquitylation,
and methylation. Of particular interest are the recent
advances in our understanding of the histone arginine * Corresponding authors.
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Cellular and Molecular Life Sciencesand lysine methylation systems, which will be dis-
cussed in this review. These modifications have been
shown to play important roles in maintaining genome
integrity, regulating transcription, and contributing to
epigenetic memory [7, 8]. Unlike some histone
modifications that can affect chromatin function by
altering the charge and structural interactions within
the nucleosome, histone methylation is a relatively
inert modification that appears to function as a
nucleation site for  effector  proteins [5]. These
effector proteins often elicit their function by recruit-
ing other factors that directly impact chromatin. To
regulate post-translational histone modifications, a
corresponding class of enzymes has evolved that can
directly remove these modifications. For example, a
class of histone demethylase enzymes has recently
been identified [9] that appear to play central roles in
regulating chromatin function.
The emergence of the histone methylation and
chromatin modification systems as important regula-
tors of cellular information has garnered much
attention and an excellent series of detailed review
articlescoveringthistopichavebeenpublished[7,10–
13]. Therefore, in this article we will provide a more
focussed discussion of the recent advances in our
understanding of how histone methylation is placed,
interpreted, and dynamically regulated in mammals.
We will also highlight a series of recent studies that
suggest histone methyltransferase/demethylase sys-
tems modify non-histone proteins, many of which
have important roles in transcription and cancer.
Histone methylation
Methylationoflysineorarginineresiduescanoccurin
several modification states. Lysine residues can house
either one (me1), two (me2) or three (me3) methyl
moieties on their amine group, whereas arginine
residues can carry one (me1) or two (me2) methyl
groups on their guanidinyl group. The di-methyl
arginine state is further defined by whether the
modification exists in the symmetric (me2s) or the
asymmetric (me2a) configuration [14]. As will be
discussedinmoredetailinlatersections,thesedefined
modification states can have different and profound
implications on the function of chromatin. The most
thoroughly studied histone lysine methylation marks
arefoundonH3K4,K9,K27,K36,K79andH4K20.In
general, H3K4, K36, and K79 methylation are found
near active or poised transcriptional units and H3K9
and H4K20 modifications are hallmarks of silenced or
heterochromatic regions. Histone arginine methyla-
tion occurs on H3R2, R8,R17 and R26 and H4R3 and
has roles in defining both active and repressed
chromatin states. Our understanding of the histone
residues that are modified by methylation has largely
been achieved by examining the in vitro substrate
specificity of histone methyltransferase enzymes and
by the generation of antibody reagents that specifi-
cally recognize modified lysine and arginine residues.
Although simple and robust, these two approaches
have clear limitations in that they either rely on the
knowledge of the enzyme that places themodification
toidentifythesiteorareessentiallypredictiveandrely
on the costly approach of modification specific anti-
bodies.
A coming of age for mass spectrometry based histone
methylation analysis
In an attempt to identify new histone methylation
marks and to study the combinatorial state of histone
modifications, a great deal of effort has been invested
in refining mass spectrometry based analysis techni-
ques. One of the goals of using mass spectrometry for
histone modification analysis is to apply relatively
unbiased methodologies in gauging and defining
cellular chromatin modification patterns, thus elimi-
nating some of the limitations inherent to enzyme and
antibodybasedapproaches.Initially, bottomup mass
spectrometry approaches were used in which histones
are fragmented into small peptides prior to ionization
andmassspectrometryanalysis(Fig.1,lefthandside).
This proved an effective tool in characterizing histone
methylationmarks,someofwhichwerenotpreviously
identified using traditional techniques. For example,
bottom up sequencing yielded evidence that
H3K79[15–17] and H4R3[18, 19] were methylated
and permitted the characterization of the enzymes
responsible for placing these modifications. Subse-
quently, more in depth histone modification analysis
has suggested methylation also occurs on: H2BK47
[20], H2BK57 [20], H2BK108 [20], H3K18 [21, 22],
H3K23 [21], H3K56 [22], H3K64 [21, 22], H3K122
[21–23], H4K59 [24], H4K31 [20, 21], H4R55 [20],
and H4K77 [20]. Although the biological relevance
and the histone methyltransferase enzymes that place
these additional modifications remain to be fully
established, bottom up strategies have proven suc-
cessful in yielding novel and potentially interesting
methylation sites.
One clear disadvantage of  bottom up  mass spec-
trometry approaches is that information about mod-
ifications that occur on the same histone tail can be
lost during the digestion step prior to ionization and
mass analysis. To overcome this limitation  top down 
approaches have been pioneered where larger frag-
ments of the histone are directly ionized prior to mass
analysis (Fig. 1, right hand side). This was recently
employedtoanalysethe50aminoacidN-terminaltail
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analysis demonstrated that the majority of histone
H3.2 modification occurs in the form of H3K9, K36,
and K27 methylation without an apparent modifica-
tionhierarchybetweenthesesitesandsuggestingthey
are independently regulated. Interestingly, the same
work also revealed that H3K4 methylation, which is
generally considered a mark of active chromatin, is
predominantly found on hyper-acetylated H3 and is
never found together with H3K9me3, a hallmark of
repressed chromatin. These molecular observations
corroborate many years of cell-based work that had
suggested this type of arrangement of histone mod-
ifications in active chromatin [26–29]. As advanced
techniques in mass spectrometry are more routinely
applied to understanding histone methylation, their
utility is becoming more obvious and applicable.
Recently top down techniques were applied to study
H4K20 methylation during the cell cycle [30]. This
work demonstrated that newly synthesized H4 is
progressively methylated to the me2 modification
state with a subset of H4K20 being methylated to the
me3 state. Furthermore, this study demonstrated that
once in place, H4K20 methylation is not dynamically
regulatedsuggestingitslevelsarenotcontrolledatthe
global level by histone demethylase activities. In
contrast to previous suggestions that H4K20 methyl-
ation and H4K16 acetylation are antagonistic mod-
ifications, mass spectrometry analysis demonstrates
that they co-exist on the same histone tail and are
independently regulated. The utility of the top down
mass spectrometry approach has been further high-
lighted by a recent study that defined the dynamics of
histone H4 modification during human embryonic
stem cell differentiation [31]. Although in its infancy
as a tool for studying histone modification, the use of
top down mass spectrometry based approaches to
understand histone methylation, the dynamics of
these modifications and their combinatorial states
has proven a powerful tool. Looking to the future,
massspectrometryapproacheswillbecomeacommon
addition to the chromatin biologist repertoire of
experimental tools.
Histone methyltransferases
Since the discovery of the first histone lysine methyl-
transferase in2000 [32],anextendedfamilyofhistone
lysine methyltransferases have been identified (re-
viewed in [7, 12]). The majority of these methyltrans-
ferases share a SET domain as their catalytic core and
Figure 1. Mass spectrometry
based approaches for studying
histone modifications. Histones
are extracted from tissue or cul-
tured cells and biochemically pu-
rified, usually by means of re-
verse phase high performance
chromatography. As the histones
elute from the column they are
fractionated and individual his-
tones are isolated (i.e. Histone
H4 in the schematic). The puri-
fied histone is then analysed
using bottom up or top down
approaches. Bottom up analysis
involves enzymatic digestion of
the histone prior to ionization,
whereas top down analysis relies
on ionization the intact histone.
Both approaches permit inter-
rogation of histone modifica-
tions, but top down approaches
have the advantage of retaining
information about modifications
that occur on the same histone.
MS - mass spectrometry.
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specificity. With the exception of a few lysine meth-
ylation sites that are of low abundance in chromatin,
the enzymes that place lysine methylation are known
and their catalytic activity are characterized. In
contrast, histone arginine methylation is placed by
the protein arginine N-methyltransferase (PRMT)
class of histone methyltransferase enzymes. Although
thehistoneresiduespecificityofthePRMTenzymesis
not as well characterized as the lysine methyltransfer-
ase enzymes, these enzymes are typically more
promiscuous and often target multiple arginine resi-
dues on the N-terminal tails of histone H3 and H4.
Furthermore, PRMT enzymes also target a broad
range of other cellular proteins suggesting they
contribute to regulation of additional non-chromatin
based processes [8].
Amorecomplexmethylationsysteminmammalswith
a division of labour
In budding yeast there is a simple histone lysine
methylation system with three prominent histone
lysine methylation marks that occur on histone H3 in
position K4, K36 and K79. The KMT2/SET1(H3K4),
KMT3/SET2(H3K36), and KMT4/DOT1(H3K79)
methyltransferase enzymes place all three methyla-
tion states (me1, me3, me3) on their respective target
residues [33]. In stark contrast to budding yeast,
mammals have a greatly expanded genomic histone
lysine methylation site modification profile, produced
by a larger family of enzymes. For example, there are
at least three proteins that place H3K36 methylation
[34–37]. Among these H3K36 methyltransferases,
individual enzymes have evolved to recognize and
target defined modification states. This is exemplified
in a recent study that demonstrated the human
KMT3A(Setd2) enzyme catalyses H3K36me3 and its
depletion in cultured cells causes an acute loss of the
me3 state but does not affect me2/1 levels [37]. This
observation suggests that H3K36me1 and me2 mod-
ification states are maintained by additional methyl-
transferases.Asimilardivisionoflabourwasobserved
when H3K36 methyltransferases were depleted in
Drosophila cells[38],suggestingthisdiversification in
modification state specificity is a feature of higher
eukaryotes.
This trend of expansion and diversification among the
histone lysine methylation system also applies to
enzymes that place other histone methylation marks.
For example, H3K4 and H3K9 methylation are
catalysed by an extended group of methyltransferase
enzymes most of which have distinct modification
state preferences in higher eukaryotes [7]. Although
there are mechanisms in budding yeast to regulate to
some extent how individual methylation states are
defined [39–42], the sheer increase in complexity of
the enzymes that place histone methylation and their
unique modification state specificity in mammals
suggest a more important role for this modification
system in higher eukaryotes. This may represent an
evolutionary adaptation that allows increased capaci-
ty for information storage through strict placement
and recognition of defined modification states by
individual methyltransferase enzymes and effector
proteins. Perhaps this expansion and specialization of
the histone methylation system helps multicellular
organisms to cope with more complex requirements
for long term chromatin based memory in controlling
gene expression patterns and tissue specificity during
development.
Histone methyltransferases as pharmacological
targets in cancer and disease
Withafirmgraspoftheidentityofmanyoftheenzymes
that place histone methylation, a significant amount of
effort has been applied to understand how these
enzymes are involved in regulating important nuclear
processes. Mouse knockout models for enzymes that
placeH3K4,H3K9,andH3K27methylationhavebeen
informative in demonstrating that methyltransferases
play important roles in regulating transcription, main-
taining genome integrity, and development [36, 43–
49]. Furthermore, enzymes involved in placing histone
methylation are targets of translocations that produce
oncogenic fusion proteins [50, 51]. The realization that
histone methyltransferases impact so many important
aspects of cellular biology has spawned a huge effort
both in the academic and industrial setting to identify
small molecule compounds that directly and specifi-
cally regulate individual histone methyltransferase
enzymes. An initial attempt to identify inhibitory
molecules used a library of natural compounds to
searchformoleculesthattargettheKMT1A(Suv39H1)
H3K9me3 methyltransferase enzymes [52]. One of the
compounds isolated in this screen, a fungal toxin
chaetocin, inhibited KMT1A in addition to a related
H3K9me1/2 methyltransferase, KMT1C(G9a). Chae-
tocin also functionally inhibited H3K9 methylation in
cell based assays, but its use as a molecular probe
appears limited due to complications with cellular
toxicity.Furthermore,fromapreclinicalstandpointthe
chemical properties of chaetocin make it a poor lead
compound for further inhibitor design.
A more recent study took advantage of a high
throughput activity based assay to screen a library of
125000chemicalcompoundsfortheirabilitytoinhibit
thehistoneH3K9me1/me2methyltransferaseenzyme
KMT1C [53]. This screen resulted in seven positive
hits based on four distinct molecular scaffolds. Of
these initial hits one compound, BIX-01294, was
410 S. S. Ng et al. Protein methylation in epigenetic signallingshown to specifically inhibit KMT1C. The function-
ality of this compound was then tested in cell-based
assays and efficiently inhibited KMT1C mediated
H3K9me1/me2 methylation at known KMT1C target
loci. Furthermore, cells treated with BIX-01294 large-
ly recapitulated global changes in histone H3K9
methylation levels observed in KMT1C deficient
cells. Although the IC50 of BIX-01294 is relatively
modest at1.7 mM,thisbase compound willprovide an
opportunity for lead optimization and synthesis of
more potent methyltransferase inhibitors. Clearly
from these initial reports reasonable scope exists for
the development of enzyme specific inhibitors of the
histonemethylationsystem.Compoundsthatarenon-
toxic and cell permeable will clearly provide impor-
tant molecular probes for studying histone methyla-
tioninthelaboratoryandprovideabasisfordesigning
compounds that are useful for pharmacological inter-
vention in human disease where the histone methyl-
ation system is perturbed.
Effectors
Unlike acetylation and phosphorylation that alter the
charge properties of a modified residue, methylation
of lysine and arginine residues is comparatively inert
and does not affect residue charge. Instead, histone
methylation acts as a nucleation site for effector
proteins that elicit functional outcome. For example,
the plant homeodomain (PHD) of the bromodomain
PHD transcription factor (BPTF) protein binds
H3K4me2/me3 (Fig. 2D) and recruits the NURF
chromatin-remodelling complex to target genes in
concert with transcriptional activation [54, 55]. In
contrast, the chromo domain of heterochromatin
protein 1 (HP1) proteins recognizes H3K9 (Fig. 2B)
methylation and helps to reinforce the repressed state
at silenced genes and heterochromatic regions of the
genome [56–58]. As we learn more about the
specificity and function of methyl-lysine binding
effector proteins it is becoming clear that these
proteins also have the capacity to preferentially
recognize defined modification states. This molecular
selectively provides the histone methylation system
with the ability to encode additional information
within each modified residue depending on the
modification state specificity of the methyltransferase
placing the modification and the effector protein that
recognizes it. Furthermore, several PHD domain
containing proteins were recently shown to have the
unique ability to recognize histone lysine residues
only when they lack methylation [59, 60]. Therefore it
appears that methylated residues act as modules
capable of encoding information that can be prefer-
entially recognized by site and state specific effector
proteins (reviewed in [5, 61]). Although the majority
of well studied histone lysine methylation marks have
corresponding effector proteins, some of the more
recently identified histone lysine modifications occur
in the core of the nucleosome and this could sterically
limit accessibility by effector proteins. It remains
possible that these methylation marks may have
effector independent roles in regulating nucleosome
structure and function. Nevertheless, over the past
year several important structural studies have high-
lighted unique properties of certain methyl-lysine
binding effector proteins (Fig. 2A–C) demonstrating
a unique complexity in chromatin recognition by
effector proteins.
One cage, two binding modes
The crystal structures of effector proteins bearing
PHD, chromo, and tudor domains have been solved
(Fig. 2A–E). A recognition motif consisting of two to
four aromatic residues that create a cage capable of
accommodating the lysine methyl ammonium group
appears to be a common chromatin recognition
interface for these domains. The KDM4A
(JHDM3A/JMJD2A) histone demethylase enzymes
contain a double tudor domain that recognizes either
H3K4 or H4K20 when modified in the me2 and me3
modification state [62]. Interestingly, the amino acid
sequence surrounding the H3K4 and H4K20 share no
significant sequence homology suggesting that mod-
ification site specificity is inherent to the tudor
domain. Whilst the structural basis for H3K4 binding
hasbeenelucidated[62],themolecularmechanismby
which the same effector could also bind H4K20 was
unknown. This was recently clarified by a study
reporting the structure of the KDM4A double tudor
domain in complex with an H4K20me3 peptide
[63](Fig. 3A). In both structures, the aromatic cage
engages the methylated H3K4 and H4K20 residues
endowing methylation dependent substrate recogni-
tion. In contrast, the bi-functional binding site specif-
icity of the hybrid double tudor domain appears to be
due to the usage of two binding interfaces. The H3K4
peptide traverses the intra-domain boundary of the
two tudor domains, whereas the H4K20 peptide
makes contacts with only one of the tudor domains.
Thereforethetwopeptidesbindtheeffectorsurfacein
opposite orientations and engage in different binding
interactions (Fig. 3A). Despite the clear specificity of
the KDM4A tudor domain for methylated histones it
remains to be determined whether this chromatin
binding motif is required to target histone demethy-
lase activity to genomic loci that also contain methy-
lated histones.
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The proximity of lysines and arginines within the
histone tails suggest there may be synergistic or
antagonistic cross-talk between adjacent modifica-
tions. Two recent studies have addressed the relation-
ship between H3K4 trimethylation, a transcription
activation mark, and H3R2 methylation. Using in
vitro peptide pull-downs, it was demonstrated that
H3R2 methylation abrogates H3K4me3 recognition
bymanyknowneffectorproteinsincludingthedouble
tudor domain of KDM4A and the PHD domains of
tumour suppressor protein ING2 (inhibitor of growth
2) and BPTF. In contrast, the PHD domain of
recombination activation gene RAG2, a component
of the VDJ recombinase, binds more efficiently to
H3K4me3 when the adjacent H3R2 residue is dime-
thylated [64, 65]. The structure of RAG2-PHD bound
to a dual-modified H3R2me2/H3K4me3 peptide re-
vealed two significant differences when compared to
other H3K4me3 binding PHD domains (Fig. 3B).
Firstly, the H3K4me3 binding site in RAG2 does not
form the typical aromatic cage, but instead has a
channel lined by two aromatic residues. Secondly, and
more interestingly, RAG2 lacks an acidic residue that
Figure 2. Effector proteins form an aromatic cage that recognizes methylated lysine residues (A-E). Cartoon representations
corresponding to the three dimensional structure of effector protein methyl-lysine binding domains (top half of each section) with a close
up view of the aromatic cage in association with a methylated ligand (bottom half of each section). (A) The KMT1D ankyrin repeat in
complex with H3K9me2 (PDB 3b95), repeats 3, 4 and 5 shown only. (B) The chromodomain of heterochromatin protein 1 (HP1) in
complex with H3K9me2 (PDB 1kna). (C) The MBTrepeats of L3MBTL1in complex with H4K20me2 (PDB 2pqw), repeat 2 shown only.
(D) The PHD finger of bromodomain PHD transcription factor (BPTF) in complex with H3K4me3 (PDB 2f6j), PHD finger shown only.
(E) The double tudor domain of KDM4A in complex with H4K20me3 (PDB 2qqs).
Figure 3. Unique substrate recognition properties of two methyl-lysine recognition domains. (A) Space filling representation of the three
dimensional structure of the KDM4A tandem-tudor domain in complex with H3K4me3 (magenta) and H4K20me3 (yellow) histone
substrates. The N- and C- terminusof the of histonepeptides are labelledand the lysine side chainis depictedprojectinginto the aromatic
methyl-lysinerecognitioncage(cyan).ThetwouniquebindingfacesofKDM4aappeartopermitthedualsubstraterecognitionproperties
ofthismethyllysinebindingeffectorprotein.(B)SpacefillingrepresentationoftheRAG2-PHDdomaininassociationwithanH3peptide
(green) containing H3K4me3 and H3R2me2s modifications. The methyl-lysine binding aromatic cage is coloured cyan and the Tyr445
residue that interacts with the symmetric dimethyl-arginine is coloured magenta.
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inotherH3K4me3recognitiondomains.IntheRAG2
PHD domain this acidic residue is replaced by a
tyrosine that favours an interaction with symmetri-
cally di-methylated H3R2. Therefore, the RAG2
PHD domain can uniquely bind H3K4me3 in the
context of H3R2me2s and may represent the first
example of a dual-mark reader.
Ankyrin and MBTrepeats – lessons for recognizing
lower methylation states
The ankyrin repeats of histone methyltransferases
KMT1C and KMT1C-like protein (KMT1D) prefer-
entially bind H3K9me1/me2 and hence represent the
newest additionto thealreadydiverseclassof methyl-
lysine effectors [66]. The structure of KMT1D bound
to an H3K9me2 peptide demonstrates that the
ankyrin repeats recognize H3K9me2 using a partially
aromatic pocket lined by tryptophans on three faces
(Trp839, 844, 877) and an acidic residue on the fourth
face (Glu847) (Fig. 2A). Importantly, the acidic
residueformsasaltbridgewiththemethylammonium
group sterically constricting the cavity and preventing
recognition of the me3 methylation state. The bio-
logical implications for the presence of domains in
KMT1C and KMT1D which recognize the same
modification that their enzymatic domain catalyses
is interesting and merits further study, but such an
arrangementcouldrepresentamechanismforspread-
ing of H3K9me1/2 from nucleation sites in silenced
chromatin.
The KMT1C and KMT1D ankyrin repeats are not
alone in preferentially recognizing lower lysine meth-
ylation states. Other examples include the 53BP1
tandem tudor domain that selectively recognizes
H4K20me1 and me2 [67] and the lethal (3) malignant
brain tumour-like protein 1 (L3MBTL1), which binds
various me1 and me2 modifications [68, 69](Fig. 2C).
Structures of these two effector molecules in complex
with methyl-lysine ligands reveal a striking similarity
withKMT1C/Dankyrinrepeatsinthearrangementof
the binding pocket. Methyl-lysine recognition occurs
in a constricted pocket with three to four aromatic
residues and a critical acidic residue. The acidic
residue again interacts with the methyl ammonium
group precluding recognition of the me3 modification
state suggesting this is the determining factor in
constricting this group of effectors to the me1 and
me2methylationstates.Insupportofthispossibility,if
a tyrosine residue in the aromatic cage of the BPTF
PHDfingerissubstitutedwithglutamicacid,thePHD
domain is converted into a me2 recognition domain
from its usual preference for the me3 modification
state.
WD40 repeats
TheWD40repeatoftheWDR5proteinwasoriginally
identified as a potential binding domain for methy-
lated H3K4. Subsequently, several structural studies
have revealed that histone binding by WDR5 occurs
through several peptide side-chain contacts to the
WD40 domain without creating a specific hydro-
phobic or aromatic cage as described for the other
methylated lysine binding modules [70–73]. Instead,
in the case of WDR5, the methylated lysyl side-chain
might be exposed to the solvent, thus allowing further
modification by histone methyltransferases [72].
Histone Demethylases
Despite the fact that global histone methylation
turnover is relatively low [74, 75] it has recently been
demonstrated that histone lysine methylation can be
dynamically regulated by histone demethylases [76,
77]. These enzymes are of two general classes. The
fist class of enzymes are amine oxidase enzymes
which are typified by the mammalian lysine specific
demethylase 1 (KDM1/LSD1) which uses FAD as a
co-factor and targets removal of the me1 and me2
modification states (Fig. 4A, top)[76]. The second
class of enzymes belongs to a large family of proteins
that contain a Jumonji-C (JmjC) domain as their
catalytic core. The JmjC domain-containing proteins
are iron and alpha-ketoglutarate dependent oxygen-
ases that target removal of all three histone lysine
methylation states (Fig. 4A, bottom). The structure
of KDM1 [78–80] (Fig. 4A, top) and KDM4A [81–
84](Fig. 4A, bottom) histone demethylases have
been solved and provided important insight into the
substrate recognition and regulatory properties of
these proteins. Interestingly, the crystal structures of
peptide substrate complexes from both types of
demethylases reveal that the active sites are pre-
dominantly polar as opposed to the largely hydro-
phobic recognition sites described above for the
effector domains [81, 85]. Not surprisingly, the
identification and characterization of histone lysine
demethylases has demonstrated that these enzymes
regulate many of the cellular processes that histone
methylation has been implicated in including tran-
scriptional regulation, maintenance of genome in-
tegrity, and regulation of epigenetic memory [9, 86].
Identification of a histone arginine demethylase
The JmjC family of proteins have been extensively
analysed for enzymatic activities that target histone
lysine methylation(reviewed in [9, 87–89]). Recent-
ly, a member of this family of proteins, JMJD6, was
shown to apparently reverse histone arginine meth-
Cell.Mol.Life Sci. Vol.66, 2009 Review Article 413ylation [90]. In contrast to previously identified
histone deiminase enzymes that convert methyl
arginine to citrulline and simply antagonize arginine
methylation [91, 92] (Fig. 4B, top), JMJD6 utilizes a
hydroxylation based reaction to directly reverse
arginine methylation. JMJD6 appears to remove
both H3R3 and H4R3 methylation and targets both
the me1 and me2 modification states. This important
discovery suggests that both arginine and histone
methylation can be dynamically regulated, but how
JMJD6 contributes to regulation of arginine meth-
ylation dependent process in vivo remains to be
examined. Interestingly, mass spectrometry analysis
of JMJD6 reacted histone substrate revealed that
JMJD6 also catalyzes oxidation of several non-
modified lysine residues. The biological relevance
of this additional activity remains elusive and war-
rants further examination.
The by-product of histone demethylation mediates
DNA damage dependent gene activation
Histone demethylation can produce reactive by-
products including formaldehyde and H2O2 that may
be damaging to chromatin and nuclear proteins.
Currently, it remains unclear if these by-products are
further metabolized to make them less harmful to the
cell or whether they have adverse affects in the
nucleus due to theirreactivenature. Inaddressing this
question, a recent study has revealed that H2O2
produced as a by-product during KDM1 mediated
demethylation at estrogen receptor (ER) target genes
results in production of 8-oxo-guanine lesions [93]
(Fig. 5A–B). This DNA damage event resulted in the
mobilizationofthe8-oxo-guanineDNAglycosylase-1
(OGG1)andtopoisomerase IIb repairenzymes tothe
regulatory regions of the gene (Fig. 5C). Surprisingly,
this DNA damage event appears to be required for
efficient transcription of the ER target genes. The
authors propose that single stranded breaks induced
during the DNA repair process may help to facilitate
DNA bending permitting more efficient RNApolII
loadingontothepromoterduringgeneactivation(Fig.
5D). Interestingly, a recent report has also implicated
agylcosylasedependentprocessinmediatingremoval
of methylated DNA bases during the same estrogen
receptor mediated gene activation event [94, 95].
Clearly, DNA breaks induced by this system could
also result in similar transcriptional outcomes as are
proposed for an H2O2 damage dependent mechanism.
In light of these two independent mechanisms for
inducing single stranded DNA breaks during ER
induced gene activation, it remains to be determined
what the relative contribution of each pathway is to
transcriptional activation. Nevertheless, it appears
that in some instances the reactive by-products of the
demethylation process may contribute in an unex-
pected way to chromatin regulation. Given that
formaldehyde is produced during JmjC-mediated
Figure 4. Proposed lysine and arginine demethylase reaction mechanisms. (A) A schematic indicating potential lysine demethylation
reaction mechanisms. (Top) Mono-methyl lysine demethylation catalyzed by JmjC domain-containing proteins using 2OG and Fe(II) as
cofactors. The reaction produces succinate, CO2, and formaldehyde as by-products. A ribbon structure of the catalytic domain of the
KDM4Ademethylaseenzymesisdepictedtotheleft(PDB2oq6).(Bottom)Theamineoxidasehistonedemethylase,KDM1,usesFADas
cofactortodemethylatemono-methyllysine.ThereactionproducesH2O2,FADH2,andformaldehydeasbyproducts.Theribbonstructure
of the KDM1 catalytic domain is depicted to the left (PDB 2v1d). (B) A schematic indicating potential arginine deimination and
demethylation reaction mechanisms. (Top) Deimination of mono-methyl arginine catalysed by the peptidylarginine PADI4 enzyme. The
ribbon structure of the PADI4 enzyme is depicted to the right (PDB 2dex). This reaction antagonizes histone arginine methylation by
converting it to citrulline. (Bottom) Demethylation of mono-methyl arginine by the JmjC domain-containing protein JMJD6. The atomic
structure of JMJD6 remains to be solved.
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and protein adducts, it is likely that a formaldehyde
scavenging system is used to inactivate this reactive
by-product. A possible candidate for this type of
reaction is the class III alcohol dehydrogenase that
uses GSH and NAD to inactivate formaldehyde [96,
97].Sincethisenzymeisalsofoundinthenucleus[98],
it will be important to determine if this system is
targeted to genomic sites undergoing histone deme-
thylation to inactivate formaldehyde.
Histone demethylases play important roles in germ
cell development and embryonic stem cell function
Although only recently JmjC domain-containing
histone demethylases were identified, there has been
a rapid advancement of our understanding of the
function of this large family of enzymes through the
use of gene knockdown and knockout strategies [99–
112]. A recent study has determined that two histone
demethylase enzymes, KDM3A (JMJD1A) and
KMD4C (JHDM3C/JMJD2C), are direct transcrip-
tional targets of the pluripotency promoting tran-
scription factor Oct-4[113]. Based on the central role
of Oct-4 in regulating embryonic stem cell (ES)
pluripotency, it was proposed that regulation of
these demethylase enzymes by Oct-4 may contribute
to downstream maintenance of stemness through
histone demethylation. To test this hypothesis
KDM3A (an H3K9me2 demethylase) and KDM4C
(an H3K9/36me3 demethylase) enzymes were
knocked-down in mouse ES cells using RNAi medi-
ated approaches. Interestingly, when these enzymes
were depleted, mouse ES cells lost their characteristic
morphologyandselfrenewalwasinhibited.LossofES
cell characteristics appeared to correlate with reduc-
tion in H3K9me levels and changes in gene expres-
sion. For example, KDM3A knockdown caused
reduced expression of the Tcl-1 gene, a known
regulator of self renewal in ES cells, and the promoter
region of the gene displayed increased levels of
H3K9me2.Furthermore,knockdownstudiesrevealed
thatKDM4CbindstotheNanoggeneandpotentiates
gene expression while counteracting H3K9me3 and
HP1 effector protein binding. Together, these obser-
vationssuggestacentralroleforH3K9demethylation
in maintaining stem cell function. Surprisingly, it has
subsequently been demonstrated that KDM3A hypo-
morphic and knockout mice are viable and grossly
normal with the exception that male mice are infertile
[114]. This suggests that although KDM3A is impor-
tant for ES cell pluripotency in cell culture, it is not
essential for normal mouse development. Neverthe-
less, in KDM3A deficient mice male sterility appears
tobecausedbyalackofexpressionofgenescentralto
the histone to protamine transition during sperm
development. Loss of normal gene expression corre-
lated with increases in H3K9me at promoter regions
suggesting that histone demethylation contributes to
regulated gene expression during germ cell develop-
ment in males. Given the complex gene expression
patterns of demethylase enzymes in mammals, it will
be important to examine in more detail how devel-
opmental and tissue specific regulation of these
interesting enzymes contributes to normal epigenetic
regulation of gene expression.
Figure5.HydrogenperoxideproducedbyLSD1duringdemethylationcontributestotranscriptionalactivation.(A)Duringtranscriptional
activationofestrogenreceptortargetgenes,KDM1removesrepressiveH3K9me2marks.(B)Aby-productofthisdemethylationreaction
ishydrogenperoxide(H2O2)whichisreactiveandcancause8-oxo-guanine(8-OG)lesionsonDNA.(C)LSD1mediated8-OGistargeted
for removal by the 8-oxo-guanine DNA glycosylase-1 (OGG1) and perhaps other components of the base excision repair system. This
repair process leads to single stranded DNA nicks that are a substrate for topoisomersase IIb (TOPO). Recruitment of topoisomeraseIIb
can lead to alterations in DNA architecture. (D) Changes in DNA architecture may aid in RNApolII loading onto target genes by
promoting chromatin accessibility or DNA bending and therefore contribute to transcriptional activation. ER – estrogen receptor.
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Although studies on protein methylation have most
recently focussed on lysyl- and arginyl methylation of
histones, it should be emphasized that methylation of
non-histoneproteinsalsooccurstoasignificantextent
(reviewed in [115]). Many important proteins have
been shown to be subject to lysine methylation,
including the tumour suppressor protein p53, a
kinetochore protein (DAM1)[116], the retinoic acid
receptor alpha [117], components of the transcrip-
tional machinery such as TAF10 [118], as well as
chloroplast (Rubisco)[119] and mitochondrial pro-
teins (cytochrome c)[120]. Furthermore, many pro-
teinsareargininemethylated,includingRNA-binding
proteins, splicing factors, coactivator p300/CBP, and
DNA polymerase b [8]. Given the importance of
histone methylation in regulation of important chro-
matin based processes, it seems likely that protein
methylation in general has important regulatory
functions and is subject to regulation by demethylase
enzymes.
Dynamic and modification state specific methylation
of p53
Lysinemethylationhasrecentlybeenidentifiedonthe
tumorsuppressorp53atthreeparticularsitesintheC-
terminaldomain[45,121–124](Fig.6).Methylationof
p53 by the KMT7(SET7/9) methyltransferase enzyme
on Lys372 in the C-terminal region of the protein
following DNA damage results in p53 stabilization
andtrans-activationofp53targetgeneslikep21[124].
Conversely, mono-methylation of Lys370 by
KMT3C(Smyd2) antagonizes association of p53 with
target genes and therefore inhibits p53 mediated
trans-activation [121]. Interestingly, when p53 is di-
methylatedonLys370thiscreatesabindingsiteforthe
tudor domain containing co-activator protein 53BP1
and permits activation of p53 target genes. These
observations suggest that differing methylation states
onthesameresidueofp53canhavediversefunctional
outcomes. In analogy to histone methylation, it was
recently demonstrated that p53 Lys370me2 methyl-
ation can be dynamically regulated by the LSD1
histone demethylase enzyme; removal of the
Lys370me2 inhibited association of p53 with 53BP1
and repressed p53 function [125]. To further the
analogy to histone modification, the same p53 lysine
residues that are methylated are also subject to other
modifications like acetylation, sumoylation and ubiq-
uitylation [126]. This suggests that cross talk or
interference between different protein modification
pathways can also occur in the post-translational
modification of p53.
A complicated and dynamic pattern of histone
methylation
Although we now know many of the enzymes that
place and remove histone methylation, it is not
completely clear how the action of these enzymatic
activities translates into genomic histone methylation
profilesinmammals.Inmanywaysthisunderstanding
hasbeenlimitedbythetechnologyusedtointerrogate
histone methylation profiles. Chromatin immunopre-
cipitation (ChIP) is the most widely used technique to
define histone methylation profiles. ChIP relies on
crosslinking histones to DNA followed by immuno-
precipitation using antibodies that recognize specific
methylation marks. This DNA is then analysed using
quantitative PCR or by hybridization to microarrays
todefinetherelativeenrichmentofamodificationata
given locus. The relatively small size of the yeast
genome has made array hybridization techniques
feasible as well as cost effective to obtain genome
wide profiles of histone methylation in this organism
[127, 128]. In mammalian systems, this type of
approach has been limited due to costs associated
witharraysthatinterrogatetheentiregenome.Recent
advances in massively parallel sequencing technolo-
Figure 6. p53 is regulated by protein methylation and demethyla-
tion. The p53 protein is made up of an N-terminal transcriptional
activation domain (TAD), a central DNA binding domain (DBD),
and a C-terminal domain (CTD). Methylation of the CTD on
Lys372 by SET7/9 occurs following DNA damage and stabilizes
p53 leading to transactivation of p53 target genes. Conversely,
mono-methylationof Lys370 by KMT3C/Smyd2 antagonizes bind-
ingofp53totargetgenesandinhibitsp53mediatedtransactivation.
Surprisingly, di-methylation of the same Lys370 residue creates a
binding site for 53BP1 leading to transactivation of p53 target
genes. Di-methylation of p53 is enzymatically reversed by the
LSD1 histone demethylase indicating that this post-translational
modification and its effects on p53 function are regulated. Recent
evidence also indicates the KMT5/Set8 enzyme methylates Lys382
in the CTD, indicating that p53 is even more broadly regulated by
lysine methylation than previously realized.
416 S. S. Ng et al. Protein methylation in epigenetic signallinggies have provided a cost-effective alternative to
analysing ChIP DNA (ChIP-Seq) and provided the
first comprehensive glance at the genome wide
histone methylation profiles [129, 130].
 ChIPing away  at histone methylation profiles in
mammals
Several important revelations regarding the methyl-
ation state of histone in mammals have arisen from
studies using ChIP-array and ChIP-seq technologies.
Firstly, histone methylation marks appear in a highly
co-ordinated fashion over genic and non-genic re-
gions. Although some of these profiles were inferred
from studies analysing isolated genomic regions in
mammals and histone methylation in model organ-
isms like budding yeast, the genome-wide view of
mammalian histone methylation indicates that there
are very specific modification patterns that share
uniformity over similar genomic elements. For exam-
ple,H3K4me3methylationisahallmarkofregulatory
elementsatthe5 endoftranscriptionallyactivegenes
or of genes poised for transcriptional activation,
whereas H3K36me3 methylation is largely restricted
to the body and 3  end of the gene [129–131]. These
observations areincloseagreementwiththetargeting
properties of the enzymes that place these modifica-
tions. For example, it is known that H3K4 methyl-
transferases are associated with transcriptional regu-
latorsthatrecognizepromoters,whereasenzymesthat
place H3K36 methylation can associate with the
elongating form of RNA pol II over the body of
genes [132]. Since the profiles of H3K4me3 and
H3K36me3 appear to be highly correlated with the
initiation and elongation of transcription, these land-
marks appear to provide a general tool in identifying
novel transcriptional units. In particular microRNA
and non-coding RNAs may be rapidly processed from
longer precursors and not readily detectable at the
mRNA level, but histone modifications over their
regulatory and genic regions highlight their existence
on chromatin [129, 130]. In non-genic regions histone
H3K9me3 and H4K20me3 silencing marks are asso-
ciated with repetitive or transposable DNA elements
including satellite sequences and long terminal re-
peats. It is thought that these marks may be placed in
response to the production of double stranded RNAs
through mobilization of the RNA interference based
transcriptionalsilencingpathwayashasbeenreported
for H3K9 methylation in other organisms.
A second important observation regarding mamma-
lian histone methylation profiles is the existence of a
specific bivalent modification pattern containing
H3K4me3 and H3K27me3 at the regulatory elements
of certain genes in ES cells [129, 133–135]. This
observation was initially very puzzling given that
H3K4me3 methylation was known to be involved in
transcriptional activation whereas the H3K27me3
modification is a part of the polycomb mediated
silencing system [136–138]. It turns out that these
bivalentdomainsarelargelyfoundatgeneswithmore
complex expression patterns including those key
developmental transcription factors [129, 135]. In ES
cells, genes with bivalent domains are largely silenced
or expressed at low levels, but during differentiation
into defined cell lineages their bivalent modification
profile is often resolved to contain either H3K4me3
methylationinconcertwithtranscriptionalactivation,
or to contain H3K27me3 and remain strongly si-
lenced. Interestingly, the recently discovered KDM6
classofhistonedemethylaseenzymes,thatremovethe
H3K27me3, were found to be part of an H3K4
methyltransferase complex [103–105, 110, 139, 140].
This suggests that bivalent domains may be resolved
by reinforcing the H3K4 methylation state while
actively removing the H3K27me3 modification.
Based on these observations, bivalent modifications
in ES cells appear to play an important role in
maintaining genes in a poised epigenetic state from
which they can be resolved to either the activated or
permanently silenced state following cellular differ-
entiation.
Although histone arginine methylation is known to
play important roles in transcription regulation, the
genomic profile in mammalian chromatin is poorly
understood. In a recent study the profiles of
H3R2me2a at a cohort of genes was analysed by
ChIPand quantitative PCR[141].Thisstudyrevealed
thatH3R2me2aisgenerallyfoundoversilencedgenes
and inhibits recruitment of H3K4 methyltransferase
enzymes by blocking effector protein recognition of
the adjacent H3K4 methylation site. Conversely,
H3K4 methylation at active genes appears to block
PRMT6 from modifying H3R2me2a [141, 142]. This
interestingobservation suggeststhatthereisaspecific
interplay between methylation at H3R2 and H3K4,
withauniqueinterdependencebetweenhistonelysine
and arginine methylation. A future challenge will be
to profile histone arginine methylation on a genome-
wide scale and to understand the functional interplay
between these modifications and other covalent
histone modifications.
Conclusions and future directions
The importance of the histone methylation system in
regulating chromatin based processes is becoming
increasingly clear as we understand more about the
enzymes which place methylation, the proteins which
Cell.Mol.Life Sci. Vol.66, 2009 Review Article 417interpret it, and the enzymes which counteract this
modification. A clear challenge for the future is to
understand and integrate how additional modifica-
tions on the same histone, within the same nucleo-
some, and in contiguous chromatin domains interact
to define local and global epigenetic histone modifi-
cation patterns. In part this will rely on mass spec-
trometry based approaches to interrogate combina-
torial modifications on individual histones and com-
prehensive genome location analysis of histone mod-
ifications using ChIP-array or ChIP-seq technologies
to understand genomic modification patterns. Armed
with a more defined understanding of the histone
modification pattern, genetic manipulation of factors
involved in defining these arrangements will help to
elucidate how modifications like histone lysine and
arginine methylation dictate or respond to epigenetic
states involved in transcription and DNA repair. A
more holistic and integrated view of the histone
modification system will be essential in defining how
these processes are perturbed and exploited in human
disease and provide potentially novel avenues for
pharmacological intervention. Clearly, with the pace
that the histone methylation and chromatin modifi-
cation fields are advancing and the new technologies
being applied to their study, more secrets of this
important epigenetic modification system will soon to
be revealed.
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